A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease
PHASE2
The purpose of this study is to determine the correct prasugrel dosage to b...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
PHASE3
This study will evaluate the relative efficacy and safety of prasugrel and ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study
PHASE4
Dual antiplatelet therapy (DAPT) with low-dose aspirin and a P2Y12 inhibito...